中文 / CN
Deutsch / DE
日本語 / JP
한글 / KR
Contact Us
菜单
Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Enhancing Governance

In the pursuit of corporate objectives, governance serves as the foundation for WuXi Biologics’ compliant and effective business management. We operate with a comprehensive governance mechanism and seek transparent dialogues with our stakeholders. Recognizing ourselves as a corporate citizen, we uphold high standards of ethical behavior and extend the same expectations to our partners and suppliers.

Governance Targets

Business Ethics
  • – Maintain 100% anti-corruption training coverage every year
  • – 100% of Board Directors participated in training on ethical standards and anti-corruption
Sustainable Supply Chain
  • – Ensure that 100% of suppliers sign the Code of Business Conduct and the Ethics of WuXi Biologics Business Partner every year
  • – Ensure 100% of procurement staff trained on sustainable procurement
ESG Management
Structure
ESG Committee
Board commitment and oversight of ESG governance
ESG Steering Group
Top leadership dedication on ESG strategy and objectives
ESG Department
ESG policies and evaluation systems for continuous performance improvement
Material Issues Task Forces and
Relevant Departments
Company-wide efforts with KPI setting to ensure implementation of ESG strategies and action plans

Business Ethics
Risk Management

  • With integrity as one of our core values, WuXi Biologics is committed to identifying and addressing any potential business ethics risks in our operations. We aspire to generate real, lasting, positive impacts on the value chain by also applying the same ethical standards to our business partners.

     

    The Ethics and Compliance Committee of WuXi Biologics, the highest management organization of the Company’s compliance system, is responsible for formulating the Company’s compliance management strategy, enhancing the Company’s compliance operations, reinforcing its ability to prevent and address compliance risks, and better navigating the challenges of an evolving global business environment.

     

    We design business ethics and compliance programs to ensure the effective implementation of our high ethical standards. Key elements include communication and training, regular audits and risk assessments, employee incentives linked to compliance, and well-established reporting and incident investigation procedures.

     

    Risk Management Process

     

  • We have established a holistic risk management system to manage risks, hazards, incidents, complaints, and claims. The system is designed to ensure the stability of our business activities by identifying, assessing, and responding to risks at an early stage.

     

IP Protection
Information Security

  • We regard intellectual property as our shared lifeline, and guard it with our founding principles of integrity, world-class security, zero-tolerance policy enforcement, and relentless pursuit of justice for any criminal act. In 2022, we remained certified with Intellectual Property Management Certificates by external organizations.

     

    Meanwhile, we are committed to respecting and protecting people’s right to data privacy in our operations and activities, paying close attention to potential information security risks, and quickly identifying and responding to security incidents and data breaches.

     

Sustainable Supply
Chain Management

  • We are committed to working with supply chain business partners who operate in line with our ethical standards and principles, and strive to integrate environmental and social sustainability into our supplier management system.

     

    Following the PSCI Principles for Responsible Supply Chain Management, we also actively engage and collaborate with our suppliers, through supplier sustainability risk assessment and responsible procurement audit, to drive best practices and bring positive impact to our value chain.In 2023, the company conducted on-site supplier audits following PSCI principles, performed by an independent accredited third-party. PSCI is a widely recognized standard adopted by pharmaceutical companies for sustainable supply chain assessment. Based on audit results, the company proposed corrective action plans for suppliers and supervised their rectification completion. PSCI principles include Ethics, Labor, Health & Safety, Environment, and Management Systems.

     

     

    High Risk

    Medium Risk

    Low Risk

    Sign the Code of Business Conduct and Ethics Commitment of Business Partners

    		 √ √ √

    Participate in annual sustainability risk assessment (desk or on-site) carried out referencing the PSCI principles

    		 √ √ √

    Participate in supplier on-site assessments carried out by contracted consultants or an independent accredited auditing body

    		 √ √ √

    Participate in our training and communication

    		 √ √ √

    Strengthen ESG performance through corrective action or improvement plans

    		 √ √  
100%

Targeted suppliers with contracts that include environmental and social clauses

icon-people
100%

New suppliers and targeted suppliers that have signed the Code of Business Conduct and Ethics of WuXi Biologics Business Partner

global-partnership-icon
100%

Procurement staff trained on sustainable procurement

application-center-icon

Certifications

  • Intellectual Property Management Certification

  • Information Security Management Certification